Overall, the pCR rate was 50.29% (n = 84), with higher pCR rates observed in the Her2-IHC 3+ cases, HR (−) cases, ER (−) cases, and with marginal significance PR (−) cases ( Table 2 ).
← all excerpts
Evaluating the Effectiveness of Neoadjuvant Therapy in Her2-Positive Invasive Breast Cancer: A Comprehensive Analysis of 167 Cases in Romania.
1
—
—